Current Appointments & Affiliations
Assistant Professor of Surgery
·
2021 - Present
Surgical Oncology,
Surgery
Member of the Duke Cancer Institute
·
2019 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
High risk surveillance MRI may not be necessary in BRCA1/2 mutation carriers over 70 years old.
Journal Article Breast Cancer Res Treat · June 2025 BACKGROUND: The risk of developing breast cancer up to age 80 for women with BRCA1/2 mutations is approximately 69-72%. The risk estimates, however, become labile in the later years of life. Many older BRCA1/2 mutation carriers who have not developed breas ... Full text Link to item CiteOutcomes of germline expedited point of care (POC) genetic testing through telehealth in the Veterans Health Administration (VA).
Conference Journal of Clinical Oncology · June 2025 1655Background: Germline genetic testing is standard of care for treatment planning for several malignancies. To increase acc ... Full text CiteMainstreaming improved adoption of germline testing for Veterans Affairs patients with metastatic prostate cancer without exacerbating disparities.
Journal Article Genet Med · May 2025 PURPOSE: To improve germline testing adoption for Veterans Affairs patients with metastatic prostate cancer (mPrCA), new delivery models were introduced to complement genetic consultation (traditional model), including mainstreaming where oncologists perfo ... Full text Link to item CiteEducation, Training & Certifications
Eastern Virginia Medical School ·
1998
M.D.
University of California, Irvine ·
1994
B.S.